355 related articles for article (PubMed ID: 31043526)
21. Pre-transplant immune factors may be associated with BK polyomavirus reactivation in kidney transplant recipients.
DeWolfe D; Gandhi J; Mackenzie MR; Broge TA; Bord E; Babwah A; Mandelbrot DA; Pavlakis M; Cardarelli F; Viscidi R; Chandraker A; Tan CS
PLoS One; 2017; 12(5):e0177339. PubMed ID: 28562595
[TBL] [Abstract][Full Text] [Related]
22. Regulation of Virus Replication by BK Polyomavirus Small T Antigen.
Zou W; Imperiale MJ
J Virol; 2023 Mar; 97(3):e0007723. PubMed ID: 36916919
[TBL] [Abstract][Full Text] [Related]
23. The Presumed Polyomavirus Viroporin VP4 of Simian Virus 40 or Human BK Polyomavirus Is Not Required for Viral Progeny Release.
Henriksen S; Hansen T; Bruun JA; Rinaldo CH
J Virol; 2016 Nov; 90(22):10398-10413. PubMed ID: 27630227
[TBL] [Abstract][Full Text] [Related]
24. Establishment of COS-BK cells persistently infected with archetype BK polyomavirus.
Nukuzuma S; Onogi H; Suzuki T
Microbiol Immunol; 2024 May; 68(5):179-184. PubMed ID: 38433377
[TBL] [Abstract][Full Text] [Related]
25. Induction and utilization of an ATM signaling pathway by polyomavirus.
Dahl J; You J; Benjamin TL
J Virol; 2005 Oct; 79(20):13007-17. PubMed ID: 16189003
[TBL] [Abstract][Full Text] [Related]
26. Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3.
Lian X; Bao C; Li X; Zhang X; Chen H; Jung YS; Qian Y
J Virol; 2019 May; 93(9):. PubMed ID: 30787154
[TBL] [Abstract][Full Text] [Related]
27. Ataxia Telangiectasia-Mutated Is Activated but Not Required for Productive Autographa californica Multiple Nucleopolyhedrovirus Infection.
Erickson JR; Kalejta RF; Friesen PD
J Virol; 2022 Nov; 96(22):e0126922. PubMed ID: 36314821
[TBL] [Abstract][Full Text] [Related]
28. Modelling BK Polyomavirus dissemination and cytopathology using polarized human renal tubule epithelial cells.
Lorentzen EM; Henriksen S; Rinaldo CH
PLoS Pathog; 2023 Aug; 19(8):e1011622. PubMed ID: 37639485
[TBL] [Abstract][Full Text] [Related]
29. The human polyomavirus BK (BKPyV): virological background and clinical implications.
Rinaldo CH; Tylden GD; Sharma BN
APMIS; 2013 Aug; 121(8):728-45. PubMed ID: 23782063
[TBL] [Abstract][Full Text] [Related]
30. BK polyomavirus nephropathy with systemic viral spread: Whole genome sequencing data from a fatal case of BKPyV infection.
Roy S; Mieczkowski PA; Weida C; Huo J; Roehrs P; Singh HK; Nickeleit V
Transpl Infect Dis; 2020 Apr; 22(2):e13269. PubMed ID: 32090422
[TBL] [Abstract][Full Text] [Related]
31. Clinically Relevant Reactivation of Polyomavirus BK (BKPyV) in HLA-A02-Positive Renal Transplant Recipients Is Associated with Impaired Effector-Memory Differentiation of BKPyV-Specific CD8+ T Cells.
van Aalderen MC; Remmerswaal EB; Heutinck KM; Ten Brinke A; Feltkamp MC; van der Weerd NC; van der Pant KA; Bemelman FJ; van Lier RA; Ten Berge IJ
PLoS Pathog; 2016 Oct; 12(10):e1005903. PubMed ID: 27723787
[TBL] [Abstract][Full Text] [Related]
32. Activation of DNA Damage Response Pathways during Lytic Replication of KSHV.
Hollingworth R; Skalka GL; Stewart GS; Hislop AD; Blackbourn DJ; Grand RJ
Viruses; 2015 Jun; 7(6):2908-27. PubMed ID: 26057167
[TBL] [Abstract][Full Text] [Related]
33. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
[TBL] [Abstract][Full Text] [Related]
34. Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients.
Abudayyeh A; Hamdi A; Abdelrahim M; Lin H; Page VD; Rondon G; Andersson BS; Afrough A; Martinez CS; Tarrand JJ; Kontoyiannis DP; Marin D; Gaber AO; Oran B; Chemaly RF; Ahmed S; Abudayyeh I; Olson A; Jones R; Popat U; Champlin RE; Shpall EJ; Rezvani K
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27862740
[TBL] [Abstract][Full Text] [Related]
35. Biology of the BKPyV: An Update.
Helle F; Brochot E; Handala L; Martin E; Castelain S; Francois C; Duverlie G
Viruses; 2017 Nov; 9(11):. PubMed ID: 29099746
[TBL] [Abstract][Full Text] [Related]
36. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
[TBL] [Abstract][Full Text] [Related]
37. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
[TBL] [Abstract][Full Text] [Related]
38. BK polyomavirus-specific antibody and T-cell responses in kidney transplantation: update.
Kaur A; Wilhelm M; Wilk S; Hirsch HH
Curr Opin Infect Dis; 2019 Dec; 32(6):575-583. PubMed ID: 31567736
[TBL] [Abstract][Full Text] [Related]
39. Impact of immune suppressive agents on the BK-Polyomavirus non coding control region.
Korth J; Anastasiou OE; Verheyen J; Dickow J; Sertznig H; Frericks N; Bleekmann B; Kribben A; Brinkhoff A; Wilde B; Sutter K; Dittmer U; Ciesek S; Witzke O; Widera M
Antiviral Res; 2018 Nov; 159():68-76. PubMed ID: 30268912
[TBL] [Abstract][Full Text] [Related]
40. The relation of NCCR variations and host transcription factors gene regulation in BK polyomavirus infected kidney transplant patients.
Sahragard I; Mohammadi A; Yaghobi R; Pakfetrat M; Afshari A; Sharifi H; Ghaemi M
Gene; 2023 Aug; 878():147567. PubMed ID: 37330024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
